Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 01:02:58 - browse：2

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Clinic falsely told dozens they had Alzheimer's, suits say

hotspot

WSS

SCOTUS to consider access to abortion pill mifepristone

FAMU bans football players from facility after release of rap video shot in team's locker room

SCOTUS to consider access to abortion pill mifepristone

Statins reduce cardiovascular risk in people living with HIV

PrEP can help anyone prevent HIV. Why do so few people take it?

After sickle

Wikipedia

Wikipedia

focus

Medicare details structure of new drug price negotiation program

Teach medical students about patients with intellectual disabilities

How to save PrEP access — and even expand it

CMS should re

BioMarin wins approval for gene therapy to treat hemophilia A

After sickle

Guidelines to prevent youth baseball injuries need more muscle

Inside the culture of fear in the White House science office of Eric Lander

Duchenne breakthrough therapy leaves behind pioneering families

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

explore

The woman behind the Dana Farber

The woman behind the Dana Farber

AI models in health care face new federal disclosure requirements

STAT letters to the editor on burnt

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Spinal cord stimulation reduces pain in amputees, study finds

explore

knowledge

hotspot

leisure time